Recent advances in the management of chronic obstructive pulmonary disease

Sharon R. Rosenberg*, Ravi Kalhan

*Corresponding author for this work

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Novel pharmacotherapies introduce additional options to providers and patients in how to best treat chronic obstructive pulmonary disease (COPD). Emerging data question the role of inhaled corticosteroids in COPD treatment, particularly as combination dual bronchodilator pharmacotherapies demonstrate robust results. For those maximized on pharmacotherapy with continued dyspnea or exacerbations or both, emerging bronchoscopic procedures may offer additional therapy in select patients. This review focuses on data supporting the use of novel ultra bronchodilators, particularly in combination, and on the role for inhaled corticosteroid withdrawal and new bronchoscopic procedures.

Original languageEnglish (US)
Article number863
JournalF1000Research
Volume6
DOIs
StatePublished - 2017

Keywords

  • COPD
  • ICS
  • LABA
  • LAMA

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Recent advances in the management of chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

  • Cite this